Categories BRAF inhibitor Harvard Medical School Medical City Dallas Melanoma nivolumab (Opdivo) Skin Cancer Zelboraf (vemurafenib)Ellis’ Stage 3A Melanoma StoryEllis E., Melanoma, Stage 3A Symptom